Market Overview

Seattle Genetics Rises On CEO's Appearance On CNBC (SGEN)


Shares of Seattle Genetics (NASDAQ: SGEN) have surged during Tuesday's trading session after the company's CEO appeared on CNBC earlier in the day. The stock has gained 4.24% to $16.49 on heavy volume. More than 2.53 million SGEN shares have already changed hands compared to a daily average of less than 1 million.

Seattle Genetics, Inc. (Seattle Genetics) is a clinical-stage biotechnology company focused on the development and commercialization of monoclonal antibody-based therapies for the treatment of cancer and autoimmune diseases.

Posted-In: Intraday Update Movers


Related Articles (SGEN)

View Comments and Join the Discussion!